East Lyme, CT, United States of America

Frank C Sciavolino


Average Co-Inventor Count = 1.2

ph-index = 7

Forward Citations = 132(Granted Patents)


Location History:

  • New London, CT (US) (1977)
  • East Lyme, CT (US) (1977 - 1981)
  • Niantic, CT (US) (1983 - 1986)

Company Filing History:


Years Active: 1977-1986

Loading Chart...
20 patents (USPTO):Explore Patents

Title: Inventor Frank C. Sciavolino: Pioneering Innovations in Immunostimulants and Antibacterial Agents

Introduction

Frank C. Sciavolino is a notable inventor based in East Lyme, Connecticut, renowned for his contributions to the field of pharmaceuticals. With a remarkable portfolio that includes 20 patents, he has significantly advanced the development of immunostimulants and antibacterial agents, demonstrating a commitment to innovation that is essential in today’s healthcare landscape.

Latest Patents

Among his latest patents, two inventions stand out. The first is related to acyltripeptide immunostimulants, which are chemically defined as acyltripeptides that form pharmaceutically acceptable salts and their intermediates. These compounds are characterized by their ability to stimulate the immune system and serve as antibacterial agents, offering potential therapeutic benefits. The second patent describes 9-dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin, which are antibacterial macrolides derived from specific structural modifications of erythromycin. These innovations reflect his commitment to addressing pressing medical needs through advanced chemical formulations.

Career Highlights

Frank C. Sciavolino's career has been marked by his tenure at Pfizer Corporation, a leading global biopharmaceutical company. His role at Pfizer has provided him with exceptional opportunities to collaborate with other talented innovators in the field. His extensive experience and expertise have allowed him to focus on developing novel therapeutic agents that have the potential to improve patient care.

Collaborations

Throughout his career, Frank has had the privilege of working alongside esteemed colleagues such as Walter D. Celmer and Walter P. Cullen. These collaborations have served as a catalyst for creative brainstorming and innovation, leading to breakthroughs that align with the company's mission to create life-saving therapies.

Conclusion

In summary, Frank C. Sciavolino stands as a prominent figure in the field of pharmaceutical innovation. His impressive array of patents showcases his dedication to improving health outcomes through the development of immunostimulants and antibacterial agents. As he continues to forge ahead in his career, the medical community eagerly anticipates the impact of his future inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…